Get the Stockscreener App
327.47
0.47%
1.53
After Hours:
327.47
Bio Rad Laboratories Inc stock is traded at $327.47, with a volume of 328.49K.
It is up +0.47% in the last 24 hours and up +1.17% over the past month.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
See More
Previous Close:
$325.94
Open:
$325.72
24h Volume:
328.49K
Relative Volume:
1.29
Market Cap:
$9.17B
Revenue:
$2.58B
Net Income/Loss:
$-778.69M
P/E Ratio:
-55.98
EPS:
-5.85
Net Cash Flow:
$223.75M
1W Performance:
-2.62%
1M Performance:
+1.17%
6M Performance:
+14.65%
1Y Performance:
+6.21%
1-Day Range:
$325.72
$334.10
1-Week Range:
$318.27
$351.08
52-Week Range:
$262.12
$387.99
Bio Rad Laboratories Inc Stock (BIO) Company Profile
Name
Bio Rad Laboratories Inc
Sector
Industry
Phone
(510) 724-7000
Address
1000 ALFRED NOBEL DRIVE, HERCULES
Compare BIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BIO
Bio Rad Laboratories Inc
|
327.47 | 9.17B | 2.58B | -778.69M | 223.75M | -27.33 |
|
ABT
Abbott Laboratories
|
114.23 | 198.13B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
364.60 | 138.99B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
88.95 | 131.10B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
81.03 | 103.90B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
74.81 | 44.12B | 6.60B | 4.16B | 490.10M | 6.93 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-01-24 | Upgrade | Citigroup | Neutral → Buy |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Apr-03-24 | Downgrade | Citigroup | Buy → Neutral |
| Dec-07-23 | Initiated | UBS | Buy |
| Jun-16-23 | Initiated | Wells Fargo | Overweight |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jan-28-22 | Reiterated | Citigroup | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Oct-17-18 | Initiated | Goldman | Buy |
| Sep-20-18 | Initiated | Morgan Stanley | Equal-Weight |
| Feb-16-18 | Downgrade | CL King | Buy → Neutral |
| Jul-13-17 | Initiated | Wells Fargo | Outperform |
| Jun-28-17 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-18-17 | Initiated | Deutsche Bank | Hold |
| Oct-13-16 | Initiated | CL King | Buy |
| May-06-15 | Reiterated | Jefferies | Buy |
| Dec-18-09 | Initiated | Maxim Group | Buy |
| Nov-06-09 | Initiated | Jefferies & Co | Buy |
| Jul-17-09 | Initiated | Soleil | Buy |
| Sep-26-07 | Initiated | Banc of America Sec | Buy |
| Feb-23-07 | Downgrade | Robert W. Baird | Outperform → Neutral |
View All
Bio Rad Laboratories Inc Stock (BIO) Latest News
FY2024 Earnings Estimate for BIO Issued By Zacks Research - MarketBeat
Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by Geode Capital Management LLC - MarketBeat
Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap DownHere's Why - MarketBeat
Bio-Rad's SWOT analysis: life science firm's stock faces mixed outlook - Investing.com
Wellington Management Group LLP Boosts Stock Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by Franklin Resources Inc. - MarketBeat
Retirement Systems of Alabama Has $7.78 Million Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
DNA/RNA Sample Extraction and Isolation Market Top Companies - openPR
Metagenomics Market to See Booming Growth 2024-2031 | Bio-Rad - openPR
Life Science Products Market Overall Study Report 2024-2031 | - openPR
DNA and RNA Sample Preparation Market Future Business - openPR
Toronto Dominion Bank Decreases Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Surface Plasmon Resonance Market Detailed In New Research - openPR
Macrophage Markers Market Top Companies StudyAbcam plc, - openPR
Bio-Rad Laboratories (NYSE:BIO.B) Trading Up 2.3%Should You Buy? - MarketBeat
Bio-Rad Laboratories, Inc. (NYSE:BIO) Sees Significant Decrease in Short Interest - MarketBeat
Is Bio-Rad Laboratories (NYSE:BIO) Using Too Much Debt? - Simply Wall St
Bio-Rad Receives NF Validation for iQ-Check Listeria spp. and iQ-Check Listeria monocytogenes Shortened Enrichment Protocol - Quality Assurance & Food Safety
Fmr LLC Lowers Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Barclays PLC Reduces Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Bio-Rad receives NF validation for iQ-Check Listeria spp. and iQ-Check Listeria monocytogenes shortened enrichment protocol in all food products and environmental samples - Cambridge Network
Chromatography Resin Market Set to Reach USD 5.1 Billion by 2032 | Increasing Demand for Biopharmaceuticals Drives Market Growth - GlobeNewswire Inc.
Global Hematology Market to Exhibit Growth at a CAGR of ~8% by 2030 | DelveInsight - The Malaysian Reserve
Bio-Rad's SWOT analysis: life science firm's stock faces growth hurdles - Investing.com Canada
Teachers Retirement System of The State of Kentucky Purchases 4,138 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Comparing Vericheck ddPCR and AUC for precise AAV therapeutic genome analysis - News-Medical.Net
Research Antibodies Market Growth in Future Scope 2024-2031 | - openPR
2,626 Shares in Bio-Rad Laboratories, Inc. (NYSE:BIO) Bought by Neo Ivy Capital Management - MarketBeat
Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by State Street Corp - MarketBeat
Cytokine Market Is Booming Worldwide 2024-2031 | Abbott, AB - openPR
Molecular Weight Marker Market Emerging Trends and Growth - openPR
Key Trends in the Cell Culture Media And Additives Market with - openPR
Human Proteome Microarray Market Industry Dynamics - openPR
Zacks Investment Management Acquires New Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
India Microfluidics Market Report 2024, with Profiles of AQC Chem. Lab, Bio-Rad Laboratories India, Abbott India, PerkinElmer India and Thermo Fisher Scientific India - Yahoo Finance
Viral Vector Purification Market Key Players AnalysisAgilent - openPR
Molecular Quality Controls Market Types and Applications, - openPR
Cell LysisCell Fractionation Market Size Estimation, Future - openPR
RNA Analysis Transcriptomics Market Key Players Analysis - openPR
Polymerase Chain Reaction (PCR) Market Size, Trends, Growth, - openPR
Bio-Rad Laboratories: Digital PCR Platform Expansion &3 Critical Factors Driving Our Optimism!Financial Forecasts - Smartkarma
Y Intercept Hong Kong Ltd Makes New Investment in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Macrophage Marker Market Landscape: Trends, Drivers, - openPR
Liquid Biopsy Market Poised for Substantial Growth (2024-2031) - openPR
In Vitro Diagnostic (IVD) Reagents Market Top PlayersThermo - openPR
Bio Rad Laboratories (BIO) Stock Surges Amid Positive Financial Performance - GuruFocus.com
Bio-Rad Laboratories (NYSE:BIO) Price Target Raised to $481.00 - MarketBeat
HbA1c Testing Market Opportunities, Challenges, and Growth - openPR
Bio-Rad Laboratories, Inc. (NYSE:BIO) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Vector Purification Market is Set to Grow with a Strong CAGR 21.3% - openPR
Key Trends in the Biochemicals Market with Insights from - openPR
Bio Rad Laboratories Inc Stock (BIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.54%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):